Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas. (Z0105)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00354822
Recruitment Status : Terminated (Inability to recruit in time a sufficient number of patients)
First Posted : July 20, 2006
Last Update Posted : September 18, 2009
Regional Hospital of Bolzano
Information provided by:
A.O. Ospedale Papa Giovanni XXIII

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : August 2009
  Actual Study Completion Date : August 2009
Publications of Results: